Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 14/20 | 0.45 |
| ▸ | CHRM2 | P08172 | 10/20 | 0.45 |
| ▸ | CHRM1 | P11229 | 10/20 | 0.45 |
| ▸ | CHRM4 | P08173 | 6/20 | 0.45 |
| ▸ | CHRM5 | P08912 | 6/20 | 0.45 |
| ▸ | RGS12 | O14924 | 1/20 | 0.45 |
| ▸ | ICMT | O60725 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiemonium SCHEMBL24577 | 0.99 | CHRM3 (0.47) | CHRM3CHRM2CHRM1CHRM4CHRM5 | |
| Tiemonium SCHEMBL1308366 | 0.90 | RGS12 (0.40) | CHRM3CHRM2CHRM1CHRM4CHRM5 | |
| Iodide SCHEMBL3366197 | 0.84 | RGS12 (0.41) | CHRM3CHRM2CHRM1CHRM4CHRM5 | |
| Thiphenamil SCHEMBL7749726 | 0.79 | MAPT (0.49) | CHRM3CHRM2CHRM1CHRM4CHRM5 | |
| SCHEMBL27463664 | 0.71 | CHRM3 (0.42) | CHRM3CHRM2CHRM1CHRM4CHRM5 | |
| Iodide SCHEMBL29558329 | 0.70 | CHRM2 (0.83) | CHRM3CHRM2CHRM1CHRM4CHRM5 | |
| Bromide SCHEMBL4467210 | 0.65 | CHRM3 (0.84) | CHRM3CHRM2CHRM1 | |
| Bromide SCHEMBL4467207 | 0.65 | CHRM3 (0.84) | CHRM3CHRM2CHRM1 | |
| Dotefonium SCHEMBL29387913 | 0.65 | CHRM3 (0.41) | CHRM3CHRM2CHRM1CHRM4CHRM5 | |
| SCHEMBL3906605 | 0.62 | RGS12 (0.44) | CHRM3CHRM2CHRM1RGS12ICMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11383084-B2 | Treatment of dermatological conditions via neuromodulation | PALO ALTO INVESTORS (US) | 2022-07-12 | — | — | US | claimed |
| EP-2956450-B1 | HYDROXYINDALPINE DERIVATIVES AND THEIR MEDICAL USE | UNIV MUENCHEN TECH (DE) | 2018-07-25 | — | — | EP | claimed |
| EP-2542228-B1 | PULSATILE DRUG RELEASE | UNIV STRATHCLYDE (GB) | 2017-11-29 | — | — | EP | claimed |
| EP-2542227-B1 | IMMEDIATE/DELAYED DRUG DELIVERY | UNIV STRATHCLYDE (GB) | 2017-11-22 | — | — | EP | claimed |
| EP-2542226-B1 | DELAYED PROLONGED DRUG DELIVERY | UNIV STRATHCLYDE (GB) | 2017-11-22 | — | — | EP | claimed |
| US-9532947-B2 | Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules | PEROVITCH PHILIPPE (FR) | 2017-01-03 | — | — | US | claimed |
| EP-2387389-B1 | COMPOSITION FOR ORAL TRANSMUCOSAL ADMINISTRATION OF ANTALGIC OR ANTISPASMODIC AGENTS | PEROVITCH PHILIPPE (FR) | 2016-06-08 | — | — | EP | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| EP-2387389-A1 | FORMULATION FOR ORAL TRANSMUCOSAL ADMINISTRATION OF ANALGESIC AND/OR ANTISPASMODIC MOLECULES | Perovitch, Philippe (FR) | 2011-11-23 | — | — | EP | claimed |
| US-20110275626-A1 | FORMULATION FOR ORAL TRANSMUCOSAL ADMINISTRATION OF ANALGESIC AND/OR ANTISPASMODIC MOLECULES | PEROVITCH PHILIPPE | 2011-11-10 | — | — | US | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| EP-1273301-B1 | Pharmaceutical preparations based on active ingredients susceptible to illicit administration | ALTERGON SA (CH) | 2006-09-06 | — | — | EP | claimed |
| EP-0956019-B1 | NOVEL THERAPEUTIC APPLICATION OF A THIENYCYCLOHEXYLAMINE DERIVATIVE | SOD CONSEILS RECH APPLIC (FR) | 2003-10-15 | — | — | EP | claimed |
| EP-1202723-A2 | USE OF ANTI-MUSCARINIC AGENTS FOR TREATING SKIN DISORDERS | Arakis Limited (GB) | 2002-05-08 | — | — | EP | claimed |
| WO-2001010427-A2 | USE OF ANTI-MUSCARINIC AGENTS FOR TREATING SKIN DISORDERS | ARAKIS LIMITED (GB) | 2001-02-15 | — | — | WO | claimed |
| EP-0956019-A1 | NOVEL THERAPEUTIC APPLICATION OF A THIENYCYCLOHEXYLAMINE DERIVATIVE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1999-11-17 | — | — | EP | claimed |
| US-5779661-A | Method of treating dysfunctional bladder syndromes by electromotive drug administration | PHYSION, S.R.L. (IT) | 1998-07-14 | — | — | US | claimed |
| WO-1998024434-A1 | NOVEL THERAPEUTIC APPLICATION OF A THIENYCYCLOHEXYLAMINE DERIVATIVE | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1998-06-11 | — | — | WO | claimed |